Scientists have created a live-cell DNA sensor that reveals how damage appears and disappears inside living cells, capturing the entire repair sequence as it unfolds. Instead of freezing cells at ...

Now sites have a new way to spy on their visitors: measuring subtle interactions with their solid-state drives. The technique ...

Most AI search guidance stops at citations. This architecture framework extends to autonomous agents completing transactions ...

The NFL schedule release week is finally here. The Denver Broncos’ full week-by-week schedule for the 2026 season — along with those of the league’s other 31 teams — were announced on the evening of ...

Is AI leaving the era of "turn-based" chat? Right now, all of us who use AI models regularly for work or in our personal lives know that the basic interaction mode across text, imagery, audio, and ...

Voice agents have been expensive to run and painful to orchestrate, not because the models can't handle conversation, but because context ceilings forced enterprises to build session resets, state ...

GPT-Realtime-2 brings GPT-5-class reasoning to live voice. A separate translation model covers 70+ input languages. A streaming Whisper variant handles transcription. The pricing is aggressive enough ...

OpenAI said Thursday that its API will now include a number of new voice intelligence features designed to help developers create apps that can talk, transcribe, and translate conversations with users ...

May 7 (Reuters) - OpenAI introduced three audio models for its developer platform on Thursday, aiming to make voice-based software agents more ‌conversational and capable of completing tasks in real ...

Please provide your email address to receive an email when new articles are posted on . Real-time clinical trials allow FDA scientists to track efficacy endpoints and safety signals while studies are ...

WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.